Edesa Biotech, Inc.EDSANASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P49
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -2.25% |
| Q3 2025 | 29.03% |
| Q2 2025 | -16.45% |
| Q1 2025 | 31.37% |
| Q4 2024 | -2.41% |
| Q3 2024 | -13.00% |
| Q2 2024 | 3.64% |
| Q1 2024 | -9.86% |
| Q4 2023 | -21.77% |
| Q3 2023 | 36.36% |
| Q2 2023 | 9.05% |
| Q1 2023 | -6.72% |
| Q4 2022 | -2.05% |
| Q3 2022 | -16.61% |
| Q2 2022 | -18.43% |
| Q1 2022 | 26.58% |
| Q4 2021 | -10.77% |
| Q3 2021 | -15.64% |
| Q2 2021 | 4.76% |
| Q1 2021 | 24.39% |
| Q4 2020 | 44.53% |
| Q3 2020 | 16.48% |
| Q2 2020 | -34.19% |
| Q1 2020 | 63.40% |
| Q4 2019 | -14.60% |
| Q3 2019 | -2.40% |
| Q2 2019 | -38.30% |
| Q1 2019 | 50.17% |
| Q4 2018 | 35.04% |
| Q3 2018 | 0.40% |
| Q2 2018 | -15.87% |
| Q1 2018 | 14.08% |
| Q4 2017 | 7.55% |
| Q3 2017 | -0.77% |
| Q2 2017 | -14.82% |
| Q1 2017 | -19.92% |
| Q4 2016 | 28.10% |
| Q3 2016 | 1.00% |
| Q2 2016 | -5.84% |
| Q1 2016 | -31.06% |